Form 8-K - Current report:
SEC Accession No. 0001104659-24-070830
Filing Date
2024-06-12
Accepted
2024-06-12 16:05:47
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416968d1_8k.htm   iXBRL 8-K 35757
  Complete submission text file 0001104659-24-070830.txt   209887

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20240606.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20240606_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20240606_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2416968d1_8k_htm.xml XML 3682
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 241038416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)